Merck announced data for its investigational Timothy grass sublingual allergy immunotherapy tablet (MK-7243), a once-daily tablet designed to help treat the underlying cause of allergic rhinitis in ...

ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergenic Extract) is the Only Sublingual Allergy Immunotherapy Tablet with a Mix of Five Grass Allergen ...

HOUSTON, Texas (KTRK) -- An exciting new and not so traditional treatment takes a different approach, offering allergy sufferers an alternative treatment. Sublingual immunotherapy also known as "Slit, ...

Stallergenes filed with the FDA to sell a first-of-its-kind sublingual allergy medication in the U.S., furthering the company's ongoing international expansion. The French company is seeking a ...

, known as MSD outside the United States and Canada, today announced that the Biologics License Application (BLA) for its investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy ...

ALK (ALKB.DC / OMX: ALK B) today announced that its European regulatory filing for ITULAZAX ® (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents aged ...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX ® for the treatment of persistent, moderate to ...

Asha Patel knows more about what goes into your lungs than you do. Every weekday at 8 a.m., the researcher climbs onto the roof of Allegheny General Hospital in Pittsburgh to check a machine called a ...

Immunotherapy tablets are starting to edge out shots as a treatment for allergies. And it looks like the pills can help reduce the frequency of asthma attacks, too. Scientists reported Tuesday that ...

LONDON--(BUSINESS WIRE)--Regulatory News: Ares Allergy Holdings plc (Stallergenes Greer) (Euronext:STAGR) today provides an update on the development of its house dust mite (“HDM”) sublingual ...

STALLERGENES S.A. (Paris:GENP) (Euronext Paris), the world leader in sublingual immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has approved ORALAIR(R) , the first ...

Immunotherapy tablets are starting to edge out shots as a treatment for allergies. And it looks like the pills can help reduce the frequency of asthma attacks, too. Scientists reported Tuesday that ...